京都大学複合原子力科学研究所 放射線生命科学研究部門
粒子線生物学研究分野

■2019

• Masunaga S, Matsumoto Y, Hirayama R, Tanaka H, Sakurai Y, Suzuki M, Sanada Y, Tano K, Maruhashi A and Ono K. Significance of manipulating tumor hypoxia and radiation dose rate in terms of local tumor control and distant lung metastasis. 105th Scientific Assembry and Annual Meeting. Chicago, USA, Dec 2019.
• Nagasaki T , Dowaki S, Kawasaki R, Matsuura K, Hattori Y, Sakurai Y, Masunaga S and Kirihata M. Cellular uptake mechanism of kojic acod modified o-carborane as a boron drug toward melanoma-targeting BNCT. 10th Young Researchers BNCT Meeting. Helsinki, Finland, Sep 2019.
• Tanaka H, Takata T, Mitsumoto T, Sakurai Y, Masunaga S, Ono K and Suzuki M. Development of neutron irradiation field for cells and small animals using cyclotron-basedepithermal neutron source. 10th Young Researchers BNCT Meeting. Helsinki, Finland, Sep 2019.
• Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Maruhashi A and Ono K. Current status of clinically available reactor- and cyclotron-based BNCT in Japan. 16th International Congress of Radiation Research (ICRR). Manchester, UK, Aug 2019.
• Masunaga S, Matsumoto Y, Kashino G, Hirayama R, Tanaka H, Sakurai Y, Suzuki M, Takata T, Maruhashi A and Ono K. Significance of manipulating tumor hypoxia and radiation dose-rate in terms of local tumor response and lung metastatic potential. 16th International Congress of Radiation Research (ICRR). Manchester, UK, Aug 2019.
• Masunaga S, Kobayashi J, Tano K, Sanada Y, Sakurai Y, Tanaka H, Takata T, Suzuki M, Maruhashi A and Ono K. The Impact of p53 Status on Radio-sensitivity of Quiescent Tumor Cell Population Irradiated with γ-Rays at Various Dose Rates. 16th International Congress of Radiation Research (ICRR). Manchester, UK, Aug 2019.

■2018

• Masunaga S, Sakurai Y, Tanaka H, Takata T, Tano K, Sanada Y, Suzuki M, Maruhashi A and Ono K. Effect of the Change in a Reactor Power on the Response of Murine Solid Tumors in Vivo, Referring to that in Intratumor Quiescent Cells and Its Clinical Significance in Boron Neutron Capture Therapy (BNCT). 104th Scientific Assembry and Annual Meeting, Radiological Society of North America. Chicago, USA, Nov 2018.
• Masunaga S. Effect of the change in reactor power on the response of murine solid tumors in vivo, also referring to that in quiescent tumor cells, and its clinical significance in boron neutron capture therapy (BNCT). 18th International Congress on Neutron Capture Therapy. Taipei, Taiwan, Oct 2018.
• Suzuki M, Kondo N, Tamari Y, Shibata E, Kijima T, Kinashi Y, Masunaga S, Takata T, Tanaka H and Sakurai Y. Boron neutron capture therapy for makignant pleural mesothelioma: Acase report. 18th International Congress on Neutron Capture Therapy. Taipei, Taiwan, Oct 2018.
• Chen L, Imamichi S, Masunaga S, Onodera T, Sasaki Y and Masutani M. The role of GM-CSF during early cellular responses after BNCR and gamma irradiation. 18th International Congress on Neutron Capture Therapy. Taipei, Taiwan, Oct 2018.
• Sanada Y, Takata T, Sakurai Y, Tanaka H, Tano K and Masunaga S. Disruption of Hif-1α enhances the sensitivity to BNCT in murine squamous cell carcinoma. 18th International Congress on Neutron Capture Therapy. Taipei, Taiwan, Oct 2018.
• Fujimoto T, Suzuki M, Kuratsu S, Sudo T, Sakuma T, Sakurai Y, Takata T, Tamari Y, Tanaka H, Masunaga S, Kinashi Y, Kondo N, Igaki H, Fujita I, Andoh T, Morishita M, Yahiro S, Shigemoto R, Kawamoto T, Akisue T, Ichikawa H, Kuroda R and Hirose T. Study on application of BNCT to synovial sarcoma. 18th International Congress on Neutron Capture Therapy. Taipei, Taiwan, Oct 2018.
• Ohmae M, Kato I, Fujita Y, Suzuki M, Masunaga S, Ono K, Sakurai Y, Nakazawa M and Uzawa N. Treatment of major cervical invasion of head and neck cancer with boron neutron capture therapy. 18th International Congress on Neutron Capture Therapy. Taipei, Taiwan, Oct 2018.
• Yanagawa M, Yanagie H, Fujino T, Matsukawa T, Kubota A, Morishita Y, Sakurai Y, Mouri K, Fujihara M, Mizumachi R, Murata Y, Nonaka Y, Novraina D, Hirata T, Shinohara A, Yokoyama K, Sugihara T, Suzuki M, Masunaga S, Sakurai Y, Tanaka H, Ono K, Nishimura R, Ono M, Nakajima J and Takahashi H. Pilot study of gadolinium accumulation in tumour with intra-arterial administration of gadoteridol-entrapped water-in-oil-in-water emulsion in VX-2 rabbit hepatic cancer model for neutron capture therapy. 18th International Congress on Neutron Capture Therapy. Taipei, Taiwan, Oct 2018.
• Dowaki S, Matsuura K, Kawasaki R, Hattori Y, Sakurai Y, Masunaga S, Kirihata M and Nagasaki T. Functional evaluation of kojic acid-modified carborane developed as a boron drug for melanoma BNCT. 18th International Congress on Neutron Capture Therapy. Taipei, Taiwan, Oct 2018.

■2017

• Masunaga S, Sakurai Y, Tanaka H, Hirayama R, Matsumoto Y, Uzawa A, Tano K, Sanada Y, Suzuki M, Kondo N, Takata T, Watanabe T, Tamari Y, Maruhashi A and Ono K. Radio-Sensitivity of Pimonidazole -Unlabeled Intratumor Quiescent Cells to γ-Rays, Accelerated Carbon Ion Beams and Boron Neutron Capture Reaction (BNCR). 9th Young Researchers' BNCT Meeting, Kyoto, Japan, Nov 2017.
• Sakurai Y, Tanaka H, Takata T, Suzuki M, Masunaga S, Kinashi Y, Kondo N, Watanabe T, Tamari Y, Sanada Y, Ono K and Maruhashi A. Present status and future plan for physical engineering and medical physics for BNCT in KURRI. 9th Young Researchers' BNCT Meeting, Kyoto, Japan, Nov 2017.
• Isono A, Masunaga S, Hirayama T, Tsuji M and Nagasawa H. Design and synthesis of new membrane permeable boron carriers for BNCT based on the pepducin technology. 9th Young Researchers' BNCT Meeting, Kyoto, Japan, Nov 2017.
• Tanaka H, Sakurai Y, Takata T, Watanabe T, Suzuki M, Masunaga S, Akabori K, Maruhashi A and Ono K. Development of real-time neutron detector and prompt gamma-ray imaging monitor for BNCT. 9th Young Researchers' BNCT Meeting, Kyoto, Japan, Nov 2017.
• Dowaki S, Matsuura K, Kawasaki R, Hattori Y, Sakurai Y, Tanaka H, Masunaga S, Kirihata M and Nagasaki T. Suppression of Melanoma Metastasis by Kojic Acid Modified Carborane. 9th Young Researchers' BNCT Meeting, Kyoto, Japan, Nov 2017.
• Fujimoto T, Kamitani N, Sudo T, Sakuma T, Aihara T, Uno M, Kanomata N, Sakurai Y, Tanaka H, Masunaga S, Kinashi Y, Kondo N, Fujita I, Andoh T, Morishita M, Yahiro S, Kawamoto T, Akisue T, Ichikawa H, Hiratsuka J, Maruhashi A, Ono K, Kuroda R, Suzuki M and Hirose T. Evaluation of Boron Neutron Capture Therapy for Leiomyosarcoma. 9th Young Researchers' BNCT Meeting, Kyoto, Japan, Nov 2017.
• Sato T, Masunaga S, Kumada H and Hamada N. Application of stochastic microdosimetric kinetic model to boron neutron capture therapy. 17th International Symposium on Microdosimetry, Venezia, Italy, Nov 2017.

■2016

• Kadoda K, Moriwaki T, Fujiike H, Tsuda M, Sasanuma H, Takada Y, Ide H, Takeda S, Masunaga S and Tano K. Anti-diabetic biguanide drugs, metformin and phenformin have genotoxicity upon glucose deprivation in chicken DT40 cells. 10th 3R (Replication, Recombination and Repair) Symposium, Matsue, Japan, 13-17 Nov 2016.
• Masunaga S, Tatebe H, Nishimura Y, Tano K, Sanada Y, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Watanabe T, Takata T, Fujimoto N, Maruhashi A and Ono K. Effect of oxygen pressure during incubation with a ¹⁰B-carrier on ¹⁰B uptake capacity of cultured p53 wild－type and mutated tumor cells with reference to dependency on p53 status of tumor cells and types of ¹⁰B-carriers. 17th International Congress on Neutron Capture Therapy, Columbia, USA, 2-7, Oct 2016.
• Masutani M, Imamichi S, Itoh T, Sato A, Kikuhara S, Fujimori H, Arai Y, Murakami Y, Itami J, Suzuki M, Ono K, Sakurai Y, Tanaka H and Masunaga S. An early inflammatory and immune cascade activation after BNCR in human cancer cells. 17th International Congress on Neutron Capture Therapy, Columbia, USA, 2-7, Oct 2016.
• Ono K, Masunaga S, Watanabe T, Suzuki M, Kondo N and Kinashi Y. CBE factors for boron compounds to the tumor varies depending on their ¹⁰B levels -radiobiological consideration about its significance-. 17th International Congress on Neutron Capture Therapy, Columbia, USA, 2-7, Oct 2016.
• Tanaka H, Sakurai Y, Takata T, Watanabe T, Suzuki M, Akabori K, Kawabata S, Masunaga S, Kondo N, Ono K and Maruhashi A. Development of a real-time prompt gamma-ray imaging system using GAGG:Ce or Srli:Eu scintillator array for BNCT. 17th International Congress on Neutron Capture Therapy, Columbia, USA, 2-7, Oct 2016.
• Yanagie H, Sato T, Dewi N, Kobayashi H, Sakurai Y, Tanaka H, Suzuki M, Masunaga S, Ono K, Nakajima J, Ono K, Eriguchi M, Hasumi K and Takahashi H. Boron delivery system using boronated polyethylene-glycol binding BSA for boron neutron capture therapy in vitro. 17th International Congress on Neutron Capture Therapy, Columbia, USA, 2-7, Oct 2016.
• Fujimoto T, Maekawa Y, Takao S, Hori A, Andoh T, Fujita I, Sakurai Y, Tanaka H, Masunaga S, Imabori M, Kitayama K, Hori S, Ichikawa H, Ono K and Suzuki M. Boron Neutron Capture Therapy (BNCT) for Axillary Lymph Node Metastasis of Breast Cancer. 17th International Congress on Neutron Capture Therapy, Columbia, USA, 2-7, Oct 2016.
• Takeuchi K, Kawabata S, Futamura G, Hiramatsu R, Kuroiwa T, Hattori Y, Kirihata M, Tanaka H, Sakurai Y, Masunaga S, Ono K and Miyatake S. Evaluation of BSH containing Kojic acid (KA-BSH) as a novel agent for boron neutron capture therapy. 17th International Congress on Neutron Capture Therapy, Columbia, USA, 2-7, Oct 2016.
• Suzuki M, Watanabe T, Kondo N, Narabayashi M, Kinashi Y, Masunaga S, Takata T, Fujimoto N, Tanaka H, Sakurai Y, Maruhashi A, Ono K. Boron neutron capture therapy for multiple liver metastases: A case report. 17th International Congress on Neutron Capture Therapy, Columbia, USA, 2-7, Oct 2016.
• Masunaga S, Tano K, Sanada Y, Sakurai Y, Tanaka H, Suzuki M, Maruhashi A and Ono K. Radiosensitivity and Capacity to Recover from Radiation-Induced Damage in Pimonidazole-Unlabeled Oxygenated Intratumor Quiescent Cells Depend on p53 Status of Tumor Cells. 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Boston, USA, 25-28, Sep 2016.
• Matsumoto Y, Yamashita K, Li H, R. Hirayama, Uzawa A, Ando K, Masunaga S, Furusawa Y, Tsuboi K and Sakurai H. The effect of uneven fractionation using high LET carbon-ion beams for tumor metastatic abilities. 55th Annual Conference of the Particle Therapy Co-operative Group, Prague, Czech Republic, 22-28, May 2016.
• Masunaga S, Tano K, Sanada Y, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Nakagawa Y, Maruhashi A and Ono K. The effect of fractionated administration of thalidomide at γ-ray irradiation on tumor response and lung metastasis. International Conference on Translational Research in Radiation Oncology - Physics for Health in Europe 2016, Geneva, Switzerland, 15-19, Feb 2016.

■2015

• Masunaga S, Sanada Y, Moriwaki T, Tano K, Sakurai Y, Tanaka H, Suzuki M, Narabayashi M, Watanabe T and Ono K. Significance of fractionated administrations of thalidomide combined with gamma-ray irradiation from the viewpoint of local tumor response and lung metastasis. 36th National Congress of Radiology, Antalya, Turkey, 20-25, Oct 2015.
• Masunaga S, Sanada Y, Moriwaki T, Tano K, Sakurai Y, Tanaka H, Suzuki M, Narabayashi M, Watanabe T and Ono K. Significance of fractionated administrations of thalidomide combined with gamma-ray irradiation from the viewpoint of local tumor response and lung metastasis. JFR 2015 (Journees francaises de Radiologie), Paris, France, 16-19, Oct 2015.
• Masunaga S, Sanada Y, Moriwaki T, Tano K, Sakurai Y, Tanaka H, Suzuki M, Narabayashi M, Watanabe T and Ono K. Significance of fractionated administrations of thalidomide combined with gamma-ray irradiation from the viewpoint of local tumor response and lung metastasis. 71st Korean Congress of Radiology, Seoul, Korea, 9-12, Sep 2015
• Masunaga S, Tano K, Sanada Y, Moriwaki T and Ono K. Characteristics of the response of intratumor quiescent (Q) cells to irradiation, referring to recruitment from Q to proliferating state. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.
• Moriwaki T, Okamoto S, Sasanuma H, Nagasawa H, Takeda S, Masunaga S and Tano K. Characteristics of differential cytotoxicity profile of tirapazamine between normoxia and hypoxia. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.
• Masunaga S, Tatebe H, Nishimura Y, Tano K, Sanada Y, Moriwaki T, Sakurai Y, TanakaH, Suzuki M, Maruhashi A and Ono K. The effect of oxygen pressure during incubation with a ¹⁰B-carrier on ¹⁰B uptake capacity of cultured p53 wild-type and mutated tumor cells. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.
• Yasui H, Nagane M, Yamamori T. Hirayama R, Kondo N, Masunaga S, and Inanami O. The effect of intermittent hypoxia on the cellular sensitivities to X-irradiation and to boron neutron capture reaction in rat glioma cells. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.
• Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Kinashi Y, Taki K, Fijimoto N, Takata T, Watanabe T, Nakagawa Y, Narabayashi M, Kondo N, Maruhashi Aand Ono K. Development of Real Time Neutron Monitors for BNCT. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.
• Matsumoto Y, Yamashita K, Li H, Kaneko Y, Sun L, Moritake T, Uzawa A, Hirayama R, Ando K, Masunaga S, Shirai T, Furusawa Y and Sakurai H. The Usefulness of Heavy-ion Beam to the Radioresistance and the Metastatic Potential Enhanced by Cyclic Hypoxia Condition. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.
• Yanagie H, Higashi S, Nakamura H, Morishita Y, Shinohara A, Fujihara M, Yanagawa M, Yui S, Suzuki M, Sakurai Y, Tanaka M, Masunaga S, Devi N, Ono K, Eriguchi M and Takahashi H. Experiences of Tumour Growth Suppression with Boron Delivery Systems in Rabbit Hepatic Cancer Model for Neutron Capture Therapy. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.
• Imamichi S, Itoh T, Sato A, Kikuhara S, Fujimori H, Hirai T, Arai Y, Murakami Y, Imahori Y, Itami J, Ono K, Sakurai Y, Tanaka H, Masunaga S, Masutani M. The Response of Cancer Cells to Boron Neutron Capture Reaction. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.
• Tada R, Hori H, Masunaga S, Kinashi Y, Ono K and Uto Y. NDT-based Approach of Boron Tracedrug UTX-51 to Glycated BSA as a AGE Model. 15th International Congress of Radiation Research (ICRR), Kyoto, Japan, 25-29, May 2015.

■2014

• Masunaga S, Sakurai Y, Tanaka H, Tano K, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Nakagawa Y, Maruhashi A and Ono K. The dependency of CBE factors on the concentration of administered neutron capture agents in BNCT. 2nd KURRI International Workshop on BNCT-Basic Science and Technology for BNCT-, Kyoto, Japan, 9-10 Dec 2014.
• Sakurai Y, Tanaka H, Takata T, Fujimoto N, SuzukiM, Masunaga S, Kinashi Y, Kondo N, NarabayashiM, Nakagawa Y, Watanabe T, Ono K and Maruhashi A. The past, present, and future of the reactor-based neutron source at Kyoto University Reactor. 2nd KURRI International Workshop on BNCT-Basic Science and Technology for BNCT-, Kyoto, Japan, 9-10 Dec 2014.
• Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Kinashi Y, Taki K, Fujii T, Fujimoto N, Takata T, Watanabe T, Nakagawa Y, Narabayashi M, Kondo N, Maruhashi A and Ono K. Development of real time neutron monitors for BNCT. 2nd KURRI International Workshop on BNCT-Basic Science and Technology for BNCT-, Kyoto, Japan, 9-10 Dec 2014.
• Nagasaki T, Kawasaki R, Hattori Y, Sakurai Y, Tanaka H, Masunaga S, Ono K and Kirihata M. Melanoma-Targeting Boron Delivery System Using Kojic Acid-Carborane Conjugate. 2nd KURRI International Workshop on BNCT-Basic Science and Technology for BNCT-, Kyoto, Japan, 9-10 Dec 2014.
• Masunaga S, Sakurai Y, Tano K, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Nakagawa Y, Maruhashi A and Ono K. Significance of Administering Bevacizumab Combined with Boron Neutron Capture Therapy in terms of Local Tumor Control and Lung Metastatic Potential. 56th Annual Meeting of American Society for Therapeutic Radiology and Oncology (ASTRO), San Francisco, USA, 14-16, Sep 2014.
• Masunaga S, Sakurai Y, Tanaka H, Tano K, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Maruhashi A and Ono K. Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis. 6th Asian Congress of Hyperthermic Oncology (ACHO)/31st Japanese Congress of Thermal Medivine (JCTM), Fukui, Japan, 5-6, Sep 2014.
• Moriwaki T, Okamoto S, Yoshimura A，Inoue E, Seki M, Masunaga S and Tano K. The depletion of antioxidant enzymes resulted differential oxidative stress and induced cell death independent of DNA damage. Gordon Research Conference on Genomic Instability, Hong Kong, China, 6-11, Jul 2014.
• Okamoto S, Narita T, Sasanuma H，Takeda S，Masunaga S，Bessho T and Tano K. Impact of DNA repair pathways on the cytotoxicity of piperlongumine in vertebrata cells. Gordon Research Conference on Genomic Instability, Hong Kong, China, 6-11, Jul 2014.
• Masunaga S, Sakurai Y, Tano K, Tanaka H, Suzuki M, Kondo N, Narabayashi3 M, Watanabe T, Nakagawa Y, Maruhashi A and Ono K. Significance of Combined Treatment with Bevacizumab in Boron Neutron Capture Therapy in Terms of Local Tumor Response and Lung Metastasis. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Yanagie H, Oyama Ｋ, Hatae R, Maruyama S, Ohno Y, Kurokawa S, Nonaka Y, Sugiyama H, FuruyaY, Taniike K, Suzuki M, Masunaga S, Kinashi Y, SakuraiY, Kondo N, Narabayashi M, Tanaka H, Maruhashi A, Ono K, Nakajima J, Ono M, Takahashi H, and Eriguchi M. Clinical Experiences of Boron Neutron Capture Therapy to Recurrenced Rectal Cancers. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Futamura G, Kawabata S, Miyatake S, Kuroiwa T, Hattori Y, Kirihata M, Tanaka H, Sakurai Y, Masunaga S and Ono K. Examination of the usefulness as the new boron compound of ACBC-BSH. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Yanagie H, Kajiyama T, Fijiwara M, Mizumachi R, Murata Y, Sakurai Y, Mouri K, Shinohara A, Matsukawa T, Oomori Y, Morishita Y, Dewi N, Yanagawa M, Higashi S, Ikushima I, Seguchi K, Yokoyama K, Iizuka T, Nonaka Y, Sugiyama H, Furuya Y, Sakurai Y, Tanaka H, Suzuki M, Masunaga S, Oyama K, Nakagawa T, Nishimura R, Ono K, Ono M, Nakajima J, Eriguchi M and Takahashi H. Feasible evaluation of WOW emulsion as intra-arterial boron delivery carrier for Neutron Capture Therapy to Hepatocellular Carcinoma. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Fujimoto N, Tanaka H, Sakurai Y, Kondo N, Narabayashi M, Nakagawa Y, Watanabe T, Kinashi Y, Masunaga S, Maruhashi A, Ono K and Suzuki M. Study on the improvement of depth dose distribution using multiple-field irradiation in boron neutron capture therapy. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Sakurai Y, Tanaka H, Fujimoto N, Kondo N, Narabayashi M, Nakagawa Y, Watanabe T, Kinashi Y, Suzuki M, Masunaga S, Maruhashi A and Ono K. A Study of Effective Dose for Tumor in BNCT. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Fujimoto N, Kinashi Y, Kondo N, Takata T, Watanabe T, Narabayashi M, Maruhashi A and Ono K. Study on the accelerator-based neutron source using Be(p,n) reaction with proton energy of lower than 30 MeV.16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Kawabata S, Miyatake S, Futamura G, Hiramatsu R, Matsushita Y, Furuse M, Tamura Y, Kuroiwa T, Tanaka H, Sakurai Y, Masunaga S, Suzuki M and Ono K. Clinical results of Boron neutron capture therapy for the patients with malignant meningioma. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Sato A, Itoh T, Fujimori H, Hirai T, Saito S, Arai Y, Murakami Y, Imahori Y, Itami J, Nakamura H, Suzuki M, Ono K, Masunaga S and Masutani M. Analysis of cell-death response and DAMPs after boron neutron capture reaction in human cancer cells 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Okamoto E, Nakai K, Yoshida F, Miyakawa M, Yamamoto Y, Tanaka H, Sakurai Y, Masunaga S, Yamamoto T and Matsumura A. Detection of plasmid strand breaks in boron neutron capture reaction. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Kondo N, Sakurai Y, Takata T, Tanaka H, Takai N, Kume K, Watanabe T, Toho T, Miyatake S, Suzuki M, Masunaga S and Ono K. Experimental trial of establishing brain necrosis mouse model using proton beam. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Hattori Y, Ishimura M, Mukumoto M, Ohta Y, Takenaka H, Uehara K, Asano T, Suzuki M, Masunaga S, Ono K and Kirihata M. Design and Synthesis of Tumor Seeking closo-Dodecaborate-Containing Amino Acids as Boron Carrier for BNCT. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Nagasaki T, Kawasaki R, Sakurai Y, Masunaga S, Ono K and Kirihata M. Kojic Acid Modified o-Carborane/Hydroxypropyl-β-Cyclo-dextrin Complex as Novel BNCT Drug for Melanoma. 16th International Congress on Neutron Capture Therapy, Helsinki, Finland, 14-19, June 2014.
• Kato I, Fujita Y,Ohmae M, Sakurai Y, Suzuki M, Masunaga S, Murata I, Sumi T, Nakazawa M and Ono K. Boron neutron capture therapy in patients with recurrent head and neck cancers who have no other treatment options. 50th Annual Meeting of the American Society of Clinical Oncology, Chicago, USA, 30 May-3 June, 2014.
• Okamoto S, Bessho T, Sasanuma H, Takeda S, Masunaga S and Tano K. Induction of double strand breaks and chromosomal aberrations by piperlongumine. 17th Biennial Meeting of Society for Free Radical Research International (SFRRI2014), Kyoto, Japan, 23-26, Mar 2014.
• Zhang-Akiyama QM, Yoshikawa Y, Ishikawa S, Miyaji M, Moriwaki T and Sanada Y. Caenorhabditis elegans oxidation resistance1 (OXR1) is essential for protection against oxidative stress and participates in the regulation of aging. 17th Biennial Meeting of Society for Free Radical Research International (SFRRI2014), Kyoto, Japan, 23-26, Mar 2014.

■2013

• Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Maruhashi A and Ono K. Significance of daily fractionated administration of wortmannin combined with gamma-ray irradiation in terms of local tumor response and lung metastatic potential. 55th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Atlanta, USA, 22-25, Sep 2013.
• Masunaga S, Tano K, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Maruhashi A and Ono K. The dependency of compound biological effectiveness factors on the type and concentration of administered neutron capture agents in BNCT. 7th Young Researchers Boron Neutron Capture Therapy Meeting, Granada, Spain, 22-26, Sep 2013.
• Sakurai Y, Tanaka H, SuzukiM, Masunaga S, KinashiY, Kondo N, Narabayashi M, Fujimoto N, Maruhashi A and OnoK. A study of boron-dose estimation using boron concentration in plasma. 7th Young Researchers Boron Neutron Capture Therapy Meeting, Granada, Spain, 22-26, Sep 2013.
• Tanaka H, Sakurai Y, Uchida R, Kawamura T, Tsuchida H, Suzuki M, Masunaga S, Kondo N, Narabayashi M, OnoK and Maruhashi A. Study on the evaluation of ¹⁰B concentration using proton-induced prompt gamma ray analysis for BNCT. 7th Young Researchers Boron Neutron Capture Therapy Meeting, Granada, Spain, 22-26, Sep 2013.
• Kondo N, Narabayashi M, Watanabe T, Tanaka H, Sakurai Y, Kinashi Y, Suzuki M, Masunaga S and Ono K. Detection of gamma H2AX foci in mouse brain tissue after neutron capture therapy. 7th Young Researchers Boron Neutron Capture Therapy Meeting, Granada, Spain, 22-26, Sep 2013.
• Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Kinashi Y, Maruhashi A and Ono K. Significance of manipulating intratumor hypoxia in terms of local tumor control and pulmonary metastatic potential in boron neutron capture therapy. 2013 Annual Meeting of the American Roentgen Ray Society, Washington DC, USA, 14-19, Apr 2013.

■2012

• Matsumoto Y, Uzawa A, Hirayama R, Koike S, Koda K, Masunaga S, Ando K and Furusawa Y. The effect of fractionated carbon-ion beams to tumor metastasis. 39th Annual Meeting of The European Radiation Research Society, Vietry sul Mare, Italy, 15-19, Oct 2012.
• Hirayama R, Uzawa A, Takase N, Koda K, Matsumoto Y, Ozaki M, Noguchi M, Kase Y, Matsufuji N, Koike S, Masunaga S, Ando K, Okayasu R and Furusawa Y. Evaluation of cell survival and micronucleus formation in clamped and non-clamped solid tumors exposed to carbon-ion beams in comparison to X-rays. 10th International Symposium on Chromosomal Aberrations, Amalfi, Italy, 19-21, Oct 2012.
• Masunaga S, Sakurai Y, Tanaka H, Hirayama R, Matsumoto Y, Uzawa A, Suzuki M, Kondo N, Maruhashi A and Ono K. Radio-sensitivity Of Pimonidazole-unlabeled Intratumor Quiescent Cells To Gamma-rays, Accelerated Carbon Ion Beams And Boron Neutron Capture Reaction. 54th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Boston, USA, 28-31, Oct 2012.
• Nagasawa H, Kimura S, Masunaga S and Okuda K. Symthesis and evaluation of cyclic RGD-boron cluster conjugates asa novel ¹⁰B-carrier for boron neutron capture therapy. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Yanagie H, Suzuki M, Sakurai Y, Inomata R, Yanagawa M, Iizuka T, Shinohara A, Mizumachi R, Murata Y, Morishita Y, Sakurai Y, Mouri K, Masunaga S, Yokoyama K, Iyomoto N, Dewi N, Sugiyama H, Nishimura R, Nakajima J, Ono M, Nakamura H, Ono K and Takahashi H. Tumor growth suppression with intra-arterial administration of BSH entrapped transferring binding PEG liposome as selectiveboron carrier in VX-2 rabbit hepatic cancer model for neutron capture therapy. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Hattori Y, Ueda S, Ohta Y, Mukumoto M, Uehara K, Asano T, Suzuki M, Masunaga S, Ono K, and Kirihata M. Acylation of ammonioundecahydro-closo-dodecaborate(1-) with activated esters for the preparation of boron carrier. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Maruhashi A and Ono K. Significance of employing boron-10 carriers and manipulating intratumor oxygenation status in terms of local tumor response and lung metastatic potential in boron neutron capture therapy. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Hirota Y, Masunaga S, Kondo N, Kawabata S, Kuroiwa T, Fujimori A, Ono K and Miyatake S. High LET-irradiation can overcome radioresistance of glioma stem-like cells which are radioresistanct with low LET-irradiation. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Tanaka H, Sakurai Y Suzuki M, Masunaga S, Mitsumoto T, Kinashi Y, Maruhashi A and Ono K. Evaluation of thermal neutron irradiation field using cyclotron based neutron source for alpha autoradiography. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Suzuki M, Suzuki O, Sakurai Y, Tanaka H, Kondo N, Kinashi Y, Masunaga S, Maruhashi A and Ono K. Reirradiation for locally recurrent lung cancer in the chest wall with boron neutron capture therapy (BNCT). 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Nakai K, Yamamoto Y, Shirakawa M, Yoshida F, Miyakawa M, Matsumura A, Tanaka H, Sakurai Y and Masunaga S. DNA breaks and cellular response induced by gadolinium neutron reaction. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Sakurai Y, Tanaka H, Suzuki M, Masunaga S, Kinasi Y, Kondo N, Ono K and Maruhashi A. Dose estimation for internal organs in body-trunk BNCT. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Yanagie H, Higashi S, Seguchi K, Ikushima I, Oyama K, Nonaka Y, Maruyama S, Hatae R, Sairenji T, Takahashi S, Suzuki M, Masunaga S, Kinashi Y, Sakurai Y, Tanaka H, Maruhashi A, Ono K, Nakajima J, Ono M, Takahashi H and Eriguchi M. Pilot clinical studyof boron neutron capture therapy for recurrent hepatic cancer and gastric cancer. 15th International Congress on Neutron Capture Therapy, Tsukuba, Japan, 9-14, Sep 2012.
• Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Maruhashi A and Ono K. Usefulness of combined treatment with continuous tirapazamine administration and mild temperature hyperthermia in gamma-ray irradiation, referring to lung metastatic potential. 11th International Congress of Hyperthermic Oncology/29th Japanese Congress of Thermal Medicine, Kyoto, Japan, 28-31, Aug 2012.
• Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A and Ono K. Impact of employing ¹⁰B-carriers and manipulating intratumor hypoxia on local tumor response and lung metastatic potential in boron neutron capture therapy. The International Conference on Translational Research in Radio-Oncology and Physics for Health in Europe (ICTR-PHE 2012), Geneva, Switzerland, 27 Feb-2 Mar 2012.
• Tano K，Inoue E，Tamari Y，Nawata H，Yoshimura A，Kashino G，Seki M，Enomoto T and Watanabe M. Optimization of intracellular reactive oxygen species levels by antioxidant peoteins in vertebrate cells. The Sugahara Memorial International Symposium, Kyoto, 26 Jan 2012.

■2011

• Masunaga S, Sakurai Y, Maruhashi A, Tanaka H and Ono K. The impact of intratumor oxygenation status on pulmonary metastatic potential, especially in terms of boron neutron capture therapy. 2011 BNCT Workshop on Clinical Applications, Taipei, Taiwan, 10, Dec 2011.
• Masunaga S, Sakurai Y and Ono K. The characteristics of ¹⁰B distribution in solid tumors in vivo following BSH or BPA administration, based on the responses of intratumor total and quiescent cell populations. 6th Young Researchers BNCT Meeting, Hsinchu City, Taiwan, 5-8, Dec 2011.
• Sakurai Y, Tanaka H, Suzuki M, Masunaga S, Kinashi Y, Kondo N, Ono K and Maruhashi A. Updated Irradiation Characteristics of the BNCT Facility in Kyoto University Reactor after the Fuel Low-Enrichment. 6th Young Researchers BNCT Meeting, Hsinchu City, Taiwan, 5-8, Dec 2011.
• Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Kinashi Y, Kondo N, Mitsumoto T, Maruhashi A and Ono K. Current Status of Cyclotron-Based Epithermal Neutron Source for BNCT. 6th Young Researchers BNCT Meeting, Hsinchu City, Taiwan, 5-8, Dec 2011.
• Kondo N, Masunaga S, Takahashi A, Sakurai Y, Suzuki M, Kinashi Y, Mori E,Ono K, Hasegawa M and Ohnishi T. Irreparable Damage for DNA Ligase IV Induced by BNCT. 6th Young Researchers BNCT Meeting, Hsinchu City, Taiwan, 5-8, Dec 2011.
• Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A and Ono K. Significance of Using a ¹⁰B-Carrier and Manipulating Intratumor Hypoxia on Local Tumor Response and Lung Metastatic Potential in Boron Neutron Capture Therapy. 53rd Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Miami Beach, USA, 2-6, Oct 2011.
• Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Kinashi Y, Kondo N, Maruhashi A and Ono K. Overview of cyclotron-based epithermal neutron source for boron neutron capture therapy. 14th International Congress of Radiation Research (ICRR), Warsaw, Poland, 28 Aug-1 Sep 2011.
• Sakurai Y, Tanaka H, Suzuki M, Masunaga S, Kinashi Y, Kondo N, Ono K and Maruhashi A. Characteristic estimation for BNCT irradiation fields - from the viewpoint of energy transfer to biological tissues. 14th International Congress of Radiation Research (ICRR), Warsaw, Poland, 28 Aug-1 Sep 2011.
• Kondo N, Takahashi A, Mori E, Noda T, Zdzienicka MZ, Thompson LH, Helleday T, Suzuki M, Kinashi Y, Masunaga S, Ono K, Hasegawa M and Ohnishi T. FANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ. 14th International Congress of Radiation Research (ICRR),Warsaw, Poland, 28 Aug-1 Sep 2011.
• Matsumoto Y, Uzawa A, Hirayama R, Koike S, Tsuruoka C, Wada M, Okayasu R, Ando K, Masunaga S and Furusawa Y. Anti-metastatic effects of carbon-ion beams for malignant tumors. 14th International Congress of Radiation Research (ICRR), Warsaw, Poland, 28 Aug-1 Sep 2011.
• Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A and Ono K. Significance of Employing a ¹⁰B-Carrier and Manipulating Intratumor Hypoxia in terms of Local Tumor Response and Lung Metastatic Potential in Boron Neutron Capture Therapy. 14th International Congress of Radiation Research (ICRR), Warsaw, Poland, 28 Aug-1 Sep 2011.
• Watanabe M, Watanabe K, Kashino G, Tano K and Kumagai J. The origin of radiation carcinogenesis is not DNA damage. 14th International Congress of Radiation Research (ICRR), Warsaw, Poland, 28 Aug-1 Sep 2011.
• Sanada U and Zhang-Akiyama QM. Caenorhabditis elegans NDX-1has an 8-oxo-7, 8-dihydrodeoxyguanosine 5'-diphosphate pyrophosphatase activity that contributes to prevent against oxidative stress. 18th International C. elegans Meeting, Los Angeles, USA, 18-19, Jul 2011.
• Sanada U and Zhang-Akiyama QM. A novel Nudix hydrolase for oxidized purine nucleoside diphosphates encoded by ndx-2 in Caenorhabditis elegans. 5th international Synposium of Biodiversity Global COE Project, Kyoto, Japan, 18-19, Jul 2011.
• Tano K, Inoue E, Yoshimura A, Seki M, Enomoto T and Watanabe M. Either SOD1, SOD2 or PRDX1 is required for normal cell growth in vertebrate cells. 2011 Gordon Research Conference on Oxidative Stress and Disease, Ventura, USA, 13-18 Mar 2011.

■2010

• Sakurai Y, Fujii T, Tanaka H, Suzuki M, Liu Y, Kashino G, Kinashi Y, Masunaga S, Ono K and Maruhashi A. A study on QA-phantom for Boron Neutron Capture Therapy. 14th International Congress on Neutron Capture Therapy, Buenos Aires, Argentina, 25-29 Oct 2010.
• Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Mitsumoto T, Fujita K, Kashino G, Kinashi Y, Liu Y, Takada M, Ono K and Maruhashi A. Experimental demonstration of beam Characteristics for cyclon-based epithermal neutron source (C-BENS). 14th International Congress on Neutron Capture Therapy, Buenos Aires, Argentina, 25-29 Oct 2010.
• Suzuki M, Tanaka H, Sakurai Y, Masunaga S, Kinashi Y, Liu Y, Maruhashi A and Ono K. A new procedure of accelerator-based BNCT at Kyoto University Research Reactor Institute (KURRI). 14th International Congress on Neutron Capture Therapy, Buenos Aires, Argentina, 25-29 Oct 2010.
• Masunaga S, Nagasawa H, Sakurai Y, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Kashino G, Tanaka H, Liu Y and Ono K. The usefulness of mild temperature hyperthermia combined with a new hypoxia-oriented ¹⁰B compund, TX-2100 for BNCT. 14th International Congress on Neutron Capture Therap, Buenos Aires, Argentina, 25-29 Oct 2010.
• Liu Y, Nagata K, Suzuki M, Chen YW, Kashino G, Masunaga S, Kinashi Y, Tanaka H, Sakurai Y, Kirihata M, Ono K. Effect of gamma-irradiation and angiogenesis inhibitor avastin treatment on distribution of blood flow and accumulation of boron compounds in murine tumors. 56th Annual Meeting of Radiation Research Society, Maui, USA, 25-29, Sep 2010.
• Ono K, Masunaga S, Kinashi Y, Suzuki M, Liu Y, Tanaka H, Sakurai Y and Maruhashi A. Selective irradiation of the blood vessels differentially suppress tumor growth. 56th Annual Meeting of Radiation Research Society, Maui, USA, 25-29, Sep 2010.
• Masunaga S, Nagasawa H, Liu Y, Sakurai Y, Tanaka H, Kashino G, Suzuki M, Kinashi Y and Ono K. Detection of the radio-sensitivity of oxygenated cell fractions in quiescent cell populations within solid tumors. The 56th Annual Meeting of Radiation Research Society, Maui, USA, 25-29, Sep 2010.
• Sanada U, Nishikawa H, Hashiguchi K and Zhang-Akiyama QM. Study for the mechanism of elimination of the oxidized nucleotides in Cenorhabditis elegans. 4th international Synposium of Biodiversity Global COE Project, Kyoto, Japan, 11-12, Sep 2010.
• Masunaga S, Matsumoto Y, Kashino G, Hirayama R, Liu Y, Tanaka H, Sakurai Y, Suzuki M, Kinashi Y, Maruhashi A and Ono K. Influence of manipulating tumor hypoxia including mild hyperthermia and radiation dose rate on local control and lung metastasis in radiotherapy. 5th Asian Congress of Hyperthermic Oncology/27th Japanese Congress of Thermal Medicine, Hakata, Japan, 10-11, Sep 2010.
• Kashino G, Kumagai J, Kugoh H, Oshimura M, Tano K, Ono K and Watanabe M. Slow releasing long lived radicals are involved in the bystander mutagenesis response. 56th Annual Meeting of the Radiation Research Society, Maui, USA, 25-29, Sep 2010.
• Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Kinashi Y, Kashino G, Liu Y, Kawabata Y, Mitsumoto T, Yajima S, Tsutsui H, Ogasawara T, Fujita K, Ono K and Maruhashi A. Beam property of intense epithermal source besed on Be(p,n) reaction using cyclotron accelerrator for borron neutron capture therapy. 49th Annual Meeting of the Particle Therapy Co-Operative Group, Maebashi, Japan, 20-22, May 2010.
• Matsumoto Y, Koike S, Uzawa A, Hirayama R, Okayasu R, Ando K, Masunaga S and Furusawa Y. The effects of heavy-ion and photon beams to mouse malignant melanoma cell line having highly metastatic potential. 49th Annual Meeting of the Particle Therapy Co-Operative Group, Maebashi, Japan, 20-22, May 2010.
• Masunaga S, Hirayama R, Uzawa A, Takata T, Tanaka H, Kashino G, Matsumoto Y, Sakurai Y, Suzuki M, Kinashi Y, Liu Y, Koike S, Maruhashi A, Ando K and Ono K. Influence of manipulating intratumor oxygenation status on radiation dose-rate effect in vivo, referring to that in quiescent tumor cell population. 49th Annual Meeting of the Particle Therapy Co-Operative Group, Maebashi, Japan, 20-22, May 2010.

• 増永慎一郎, 櫻井良憲, 鈴木実, 田中浩基, 丸橋晃, 田野恵三, 真田悠生, 近藤夏子, 渡邉翼, 高田卓志, 小野公二, 「抗腫瘍効果から見た中性子捕捉療法の治療生物学的解釈」, 第45回放射線による制癌シンポジウム, 大阪, 15, Jul 2016.
• 増永慎一郎, 「腫瘍内微小環境とハイパーサーミア」, 第18回関西ハイパーサーミア研究会, 京都, 26, Jun 2016.
• 真田悠生, 田野恵三, 増永慎一郎, 「腫瘍細胞のメトフォルミン感受性についてHIF-1α欠損が及ぼす効果」, 第18回癌治療増感研究シンポジウム, 奈良, 5-6, Feb 2016.
• 増永慎一郎, 「治療生物学的および放射線治療医的視点から見た中性子捕捉療法の特性」, 第34回日本口腔腫瘍学会総会・学術大会, 横浜, 21-22, Jan 2016.
• 増永慎一郎, 西村恭昌, 平岡真寛, 小野公二, 「マイルドハイパーサーミアの腫瘍生物学的特性解析と局所腫瘍制御への応用」, 第32回日本ハイパーサーミア学会学術大会, 大阪, 4-5, Sep 2015.
• 増永慎一郎「日本中性子捕捉療法学会BNCT人材育成委員会の活動報告」, 第13回日本中性子捕捉療法学会学術大会, 東京, 7, Aug 2016.
• 増永慎一郎, 「BNCTを含む放射線治療において腫瘍内酸素状況が及ぼす局所制御率と肺転移能への影響」, 第13回日本中性子捕捉療法学会学術大会, 東京, 6, Aug 2016.
• 増永慎一郎, 「治療生物学的視点から見た癌治療法としての中性子捕捉療法の特徴」, アイソトープ放射線薬学研究会, 神戸, 26, Mar 2015.
• 増永慎一郎, 「治療生物学的および放射線治療医的視点から見た癌治療法としての中性子捕捉療法の特性」, 第3回つくば放射線治療を学ぼう会, つくば, 7, Mar 2015.
• 真田悠生, 森脇隆仁, 田野恵三, 増永慎一郎, 「低グルコース環境を標的とした腫瘍内休止細胞増感作用向上の試み」, 第17回癌治療増感研究シンポジウム, 奈良, 6-7, Feb 2015.
• 増永慎一郎, 「放射線治療医が見た中性子捕捉療法―治療生物学的視点からみた感想―」, 札幌医科大学放射線治療セミナー, 札幌, 29, Oct 2014.
• 増永慎一郎, 田野恵三, 櫻井良憲, 田中浩基, 鈴木実, 近藤夏子, 楢林正流, 仲川洋介, 渡邉翼, 真田悠生, 森脇隆仁, 丸橋晃, 小野公二, 「治療生物学的解析から見た硼素中性子捕捉療法(BNCT)の特性」, 日本放射線影響学会第57回大会 粒子線治療生物学の進展をめざして（ワークショップ８）, 鹿児島, 2, Oct 2014.
• 増永慎一郎, 「¹⁰B化合物投与法の統一化の可能性について」, 第11回日本中性子捕捉療法学会学術大会, 大阪, 6, Jul 2014.
• 増永慎一郎, 「治療生物学的解析から見た¹⁰B薬剤の動態・集積」, 日本中性子捕捉療法学会 第2回BNCT講習会, 大阪, 4, Jul 2014.
• 増永慎一郎, 田野恵三, 小野公二, 「治療抵抗性休止期腫瘍細胞の特性から見た放射線増感」, 第20回癌治療増感研究会, 高知, 7, Jun 2014.
• 増永慎一郎, 「放射線感受性を修飾する内因性及び外因性因子」, 第4回放射線生物学セミナー, 枚方, 25, Jan 2014.
• 増永慎一郎, 「癌治療、特に放射線治療における休止期腫瘍細胞制御の意義－（付）局所腫瘍からの転移能の制御－」, 日本動物実験代替法学会第２６回大会シンポジウム, 京都, 19-21, Dec 2013.
• 増永慎一郎, 田野恵三, 鈴木実, 近藤夏子, 楢林正流, 渡邉翼, 小野公二, 「ピモニダゾール非標識酸素化休止期腫瘍細胞分画における放射線損傷からの回復に対するティラパザミン処置，低温度温熱処置の影響」, 日本ハイパーサーミア学会第30回大会, 横浜, 30-31, Aug 2013.
• 増永慎一郎, 田野恵三, 櫻井良憲, 田中浩基, 鈴木実, 近藤夏子, 楢林正流, 渡邉翼, 丸橋晃, 小野公二, 「中性子捕捉療法（BNCT）における腫瘍内低酸素の意義」, 第42回放射線による制癌シンポジウム, シンポジウムI : 低酸素状態と放射線感受性, 仙台, 5, Jul 2013.
• 増永慎一郎, 田野恵三, 小野公二, 「休止期腫瘍細胞の挙動に及ぼす分割照射の影響について」, 次世代がん治療推進専門家養成プラン　シンポジウム～癌治療抵抗性機構とその克服～(Part II), 放射線治療の潮流－Hypofractionationの基礎と臨床－, 東京, 8, Jun 2013.
• 増永慎一郎, 「放射線感受性を修飾する内因性及び外因性因子」, 第3回放射線生物学セミナー, 東京, 2, Feb 2013.
• 増永慎一郎, 松本孔貴, 平山亮一, 櫻井良憲, 田中浩基, 鵜澤玲子, 鈴木実, 近藤夏子, 丸橋晃, 小野公二, 「通常放射線照射および中性子捕捉療法後の局所腫瘍効果と肺転移抑制効果における腫瘍内酸素状況修飾処置併用の意義」, 第41回放射線による制癌シンポジウム : 基礎と臨床の対話, 宜野湾, 29, Jun 2012.
• 増永慎一郎, 「酸素標的・増感放射線療法KORTUCの基礎と臨床、放射線治療効果の修飾因子について」, 日本放射線腫瘍学会第２４回学術大会 シンポジウム, 神戸, 17-19, Nov 2011.
• 増永慎一郎, 松本孔貴, 平山亮一, 櫻井良憲, 田中浩基, 鈴木実, 近藤夏子, 丸橋晃, 小野公二, 「局所腫瘍内低酸素領域の修飾が及ぼす遠隔肺転移能への影響-局所腫瘍制御と遠隔転移能抑制の同時達成に向けて-」, 日本放射線影響学会第54回大会, 神戸, 17-19, Nov 2011.
• 増永慎一郎, 櫻井良憲, 田中浩基, 鈴木実, 近藤夏子, 丸橋晃, 小野公二, 「中性子捕捉療法における低温度温熱処置など腫瘍内酸素化状況修飾の意義について」, 日本ハイパーサーミア学会第28回大会, 名古屋, 9-10, Sep 2011.
• 増永慎一郎, 劉勇, 田中浩基, 櫻井良憲, 鈴木実, 近藤夏子, 丸橋晃, 小野公二, 「アバスチン処理による固形腫瘍内急性低酸素細胞分画の低下と肺転移抑制効果について」, 第13回癌治療増感研究シンポジウム, 奈良, 11-12, Feb 2011.
• 増永慎一郎, 鈴木実, 菓子野元郎, 木梨友子, 安藤興一, 小野公二, 「休止期腫瘍細胞の挙動から見た分割照射」, 第40回放射線による制癌シンポジウム, 札幌, 10, Jul 2010.
• 増永慎一郎, 「Reoxygenation現象の解析と低酸素細胞分画に関するin vivo治療生物的考察」, 第12回癌治療増感研究シンポジウム, 奈良, 13-24, Feb 2010.